Radiographical, Histomorphometrical and Biomarker Analysis After Maxillary Sinus Augmentation Utilizing Xenograft Particulate Bone Graft Mixed With Parathyroid Hormone
Recruiting
Phase 4
Interventional Study
Maxillary Sinus Augmentation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 30 (estimated)
- Sponsor
- University of Baghdad · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aimed the to investigate the beneficial effect of combining PTH with bovine-derived bone graft bone in maxillary sinus augmentation.
There is limited information available about the effect of PTH on maxillary sinus augmentation to achieve a clear understanding of PTH's efficacy in bone regeneration and bone remodelling through radiological, clinical, biomarker, histological and histomo…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria
* Healthy individuals without any systemic disease/local pathological lesion at the sinus zone that compromise the bone healing potential.
* Fair to good oral hygiene.
* Patient's age ≥ 18 years.
* The RBH was 3 mm or less. Atrophic edentulous posterior maxillary ridge (missing t…
Contacts
Mohanad Ali Ali Shabat, Msc,PhD student in Oral surgey
009647804305996
CONTACT